BioSpace News Archive

A national advocacy organization is warning anyone concerned about COVID-19 symptoms to get tested for another deadly disease: Legionnaires’ disease.

AMRA’s research, in collaboration with Linköping University, proposes a standardized muscle-specific metric using magnetic resonance imaging (MRI) to detect a vulnerable muscle phenotype within non-alcoholic fatty liver disease (NAFLD) and recommends strengthening of future sarcopenia guidelines by the introduction of cut-off values for muscle fat.

Eppendorf AG announces the release of its new Move It® Adjustable Spacing Pipettes.

M.S.Q. Ventures announced that its client, BioInvent International, AB, has successfully entered into a licensing agreement with CASI Pharmaceuticals, Inc. for the development and commercialization of BI-1206 in the Greater China region.

Summit Venture Studio overcomes commercialization challenges to accelerate time to market for university-originated software

FzioMed, Inc., a leading biomaterials company, is pleased to announce that Oxiplex shipments have now passed the 600,000 unit mark.

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today announced the pricing of an underwritten public offering of 80,000,000 units at a price of $0.10 per unit. Each unit issued in the offering consists of one share of common stock and one warrant to purchase one share of common stock. Gross proceeds, before underwritin

Emunamedica LLC, a wound diagnostics company announced today that Podascan™, its chronic wound diagnostic device had received Breakthrough Device Designation from the United States Food & Drug Administration (FDA).

These specialties also rank among the best programs in the U.S, providing Florida patients with a clear choice and resource to receive world-class care

Leader in Cloud Revenue Management Uncovers the Industry’s Focus on Finding New Efficiencies, Managing Revenue and Changing the Dialog on Drug Pricing